Drug compliance in patients with bronchial asthma: Relation among compliance with different types of antiasthmatic drug and association with daily administration frequency

Allergology International

Volumn 54, Issue 4, 2005, Pages 547-553

  Hasegawa, Takashi ^a   Suzuki, Eiichi ^b   Toyabe, Shinichi ^b   Akazawa, Kouhei ^b   Kawano, Kenji ^c   Haraguchi, Michihiko ^d   Toyama, Joji ^e   Watanabe, Yoko ^f   Watanabe, Noriko ^f   Arakawa, Masaaki ^a   Satoh, Hiroshi ^b   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^d NIIGATA CITY GENERAL HOSPITAL   (Japan)

^e Joetsu General Hospital   (Japan)

^f Niigata Pharmacy   (Japan)

Author keywords

Bronchial asthma; Drug compliance; Inhaled corticosteroid; Leukotriene receptor antagonist; Oral sustained released theophylline

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 33749257924     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.54.547     Document Type: Article

References (22)

1. Makino S, Furusho K, Miyamoto T, Ohta K. Asthma Prevention and Management Guidelines. 1998, Japan (JGL): English version. Int. Arch. Allergy. Immunol. 2000;121:1-78.
2. National Institute of Health. National Asthma Education and Prevention Program. "Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002". Bethesda:National Institute of Health, 2002.
3. Suzuki E, Hasegawa T, Koya T et al. Questionnaire-based Analysis of Current Status of Adult Bronchial Asthma in Niigata Prefecture. Acta Med. Biol. 2002;50:135-143.
4. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnesr PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N. Engl. J. Med. 1997;337:1412-1418.
5. Condemi JJ, Goldstein S, Kalberg C et al. The Addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann. Allerg. Asthma Immunol. 1999;82:383-389.
6. Yurdakul AS, Calisir HC, Tunctan B, Ogretensoy M. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. Respir. Med. 2002;96:322-329.
7. Cramwers JA, Spilker B. Patients Compliance in Medical Practice and Clinical Trials. New York:Raven Press, 1991.
8. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br. J. Gen. Pract. 1990;40:114-116.
9. Leenen FH, Wilson TW, Bolli P et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Canadian J. Cardiol. 1997;13:914-920.
10. Iskedjian M, Einarson TR, MacKeigan LD et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a metaanalysis. Clin. Therapeutics 2002;24:302-316.
11. van Schayck CP, Bijl-Hofland ID, Folgering H, Cloosterman SGM, Akkermans R, van den Elshout F. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scandi. J. Primary Health Care 2002;20:126-128.
12. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117:542-550.
13. Jonasson G, Carlsen KH, Sodal A, Jonasson C, Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur. Respir. J. 1999;14:150-154.
14. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am. J. Respir. Crit. Care Med. 1998;157:1810-1817.
15. Yeung M, O'Connor SA, Parry DT, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir. Med. 1994;88:31-35.
16. Mann MC, Eliasson O, Patel K, ZuWallack RL. An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992;102:1342-1346.
17. van der Palen J, Klein JJ, Rovers MM. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur. Respir. J. 1997;10:652-657.
18. Van Grunsven PM, van Schayck CP, van Herwaarden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA). J. Asthma 2000;37:225-234.
19. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch. Intern. Med. 1994;154:1349-1352.
20. Hasegawa T, Suzuki E, Koya T et al. Analysis of drug compliance in adult patients with bronchial asthma. Based on questionnaire surveys in Niigata Prefecture, Japan. General Medicine 2004;5:7-11.
21. van der Woude HJ, Aalbers R. Compliance with inhaled glucocorticoids and concomitant use of long-acting beta 2 agonists. Respir. Med. 2001;95:404-407.
22. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J. Allergy Clin. Immunol. 2004;113:245-251.